Sitemap

75 Years Of Galenika

More...

News

ATP Tour To Return To Belgrade In 2021, Following Budapest Relocation

The Hungarian Open, an ATP 250 clay-court tournament hosted in Budapest from 2017-2019, has been approved for relocation to Belgrade,...

Businesspeople From Serbia And The Entire World Can Enter Our Country Even Without A PCR Test!

At the initiative of the Chamber of Commerce and Industry of Serbia, as of 21 January,  businesspeople from the...

The Serbian Government Adopted A Set Of Decrees In The Field Of The Economy For 2021

The Serbian government adopted a set of decrees in the field of the economy for 2021, which encourage regional...

TRAG Foundation Announces Fourteenth Competition Of The Virtus Award For Philanthropy

Trag Foundation has announced the launch of the competition for the 14th Annual VIRTUS Award for Philanthropy. This competition...

Novak Djokovic’s Open Letter After Facing Criticism For Quarantine Demands in Australia

World No 1 Novak Djokovic published an open letter to the Australian public on Twitter on Wednesday in which...

In the jubilee year, Galenika a.d. Belgrade records constant growth in all segments of its business. In the first half of 2020, Galenika achieved an increase in sales by 8% compared to the same period in 2019, which strengthened its second position in the Serbian pharmaceutical market.

The direct result of the new vision and business strategy resulted in additional sales growth in the region (Montenegro, Bosnia and Herzegovina, Northern Macedonia) by 14%. Three new export markets have been opened, while Galenika is actively present in 8 international markets in the EU, the Middle East and Africa, where it has increased its sales more than double.

With a strategic partnership with its sister company from Brazil – EMS, Galenika’s Institute for Research and Development continues to develop new products. The registration of 12 products is in progress, and by the end of the year, 4 new products are expected to be released on the market. Additionally, in the first half of 2020, the production of the range of its own products increased by 5% compared to the same period in 2019.

As a responsible company, Galenika successfully implements environmental protection measures and has achieved goals that are in line with the strict requirements of ISO 14001 standards. Waste generation has been reduced since the privatization and a strict waste management procedure has been applied, while CO2 emissions have been reduced by 20% and electricity use by 10%.

” We are working to further increase production and sales in the Serbian and international markets, explore innovative ways to promote our existing products and are committed to significant portfolio growth – by registering and launching five new products per year, over the next five years. Our strategic goal is the development of Galenika, while in parallel, we do not exclude the possibility of further expansion through acquisitions, “said Ricardo Vian Marques, General Manager of Galenika.

In the field of digitalization, Galenika has already entered the transformation of Industry 4.0 and Smart Manufacturing with the implementation of the Internet of Things in production. As the first company in the region, state-of-the-art advanced business process management software, SAP S4HANA in the Cloud, has been implemented, as well as an innovative Business-to-Business platform that enables customers to purchase through the latest digital experience, anytime, anywhere.

“Galenika has been the Guardian of Health for 75 years. Especially in times like these, we see how important that is. We are proud of the 75-year tradition of the company and incomparable expertise, but at the same time in Galenika I see people who are 100% focused on the future. That is why I have great confidence in our local team and Galenika becoming a regional leader “, Marques concluded.

Related Articles

Ljiljana Topić, Director, Galenika Pharmacia

We’re Here When Times Are Hardest

Galenika Pharmacia is a factory that produces complete sanitary consumables – from compresses, gauzes and bandages, via disinfectants, to surgical masks that have become...

Galenika: What is most valuable to all of us?

At the time of the pandemic, the company Galenika a.d. is, more intensively than ever, dedicated to its most important task - preserving human...

Galenika donates Hydroxychloroquine Sulfate worth 400,000 Euro in fight against COVID-19

Galenika a.d. Belgrade produced and placed 372,000 tablets of the medicine Hydroxychloroquine Sulfate on the disposal of the Government of Serbia The value of the...

Ljiljana Topić, Director of Galenika Pharmacia

Expanding Production And Markets

Galenika Pharmacia emerged through separation from company Galenika Holding seven years ago, with the aim of contributing to the improvement of quality of life...

74 Years of Galenika: Investments And Business Success In The First Half Of 2019

Demonstrating the vision and readiness to adapt to the latest business trends and market demands, the domestic pharmaceutical company Galenika a.d., which became part...